Skip to main content

Indications for Surgical Treatment in Ulcerative Colitis and Crohn’s Disease

  • Chapter
Operative Strategies in Inflammatory Bowel Disease

Abstract

Ulcerative colitis and Crohn’s disease represent a disease spectrum with protean manifestations and complications. Although as many as half of all patients with inflammatory bowel disease require at least one surgical procedure to address complications derived from their disease, the decision in favor of a surgical approach and its timing is rarely an easy one. Important considerations entering in the final decision include the localization of the disease, the amount of diseased bowel, the length of grossly normal intestine, the feasibility of bowel-sparing procedures in Crohn’s disease, the likelihood that a temporary or permanent stoma may be necessary and the changes in the quality of life that surgery may produce. Other factors such as personal or work-related commitments may also influence timing of the surgical treatment. Due to the need to balance objective findings with personal considerations, it is essential that the patient, the gastroenterologist and the surgeon, assisted by the radiologist and the pathologist, partake in the decision of the optimal treatment plan for the patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 279.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 379.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Michelassi F, Finco C. Indications for surgery in inflammatory bowel disease: the surgeon’s perspective. Kirsner JB, Shorter RG, eds. Inflammatory Bowel Disease 4th ed. Baltimore: Williams & Wilkins; 1995: 771–783.

    Google Scholar 

  2. Kirsner JB, Palmer WL, Spencer JA, et al. Corti-cotropin (ACTH) and adrenal steroids in the management of ulcerative colitis: observations in 240 patients. Ann Int Med 1959;50:89.

    Google Scholar 

  3. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut 1963;4:299.

    Article  PubMed  CAS  Google Scholar 

  4. Korelitz B, Lindner AE. The influence of corti-cotrophin and adrenal steroids in the course of ulcerative colitis: a comparison with the presteroid era. Gastroenterology 1964;46:671.

    PubMed  CAS  Google Scholar 

  5. Meyers S, Sachar DB, Goldberg JD, et al. Corti-cotropin versus hydrocorticosone in the intravenous treatment of ulcerative colitis: prospective, randomized, double-blind clinical trial. Gastroenterology 1983;85:351.

    PubMed  CAS  Google Scholar 

  6. Lichtiger S, Present DH, Kornbluth A, et al. Cyclo-sporin in severe ulcerative colitis refractory to steroid therapy. New Engl J Med 1994;330(26):1841–1845.

    Article  PubMed  CAS  Google Scholar 

  7. Norland C, Kirsner JB. Toxic dilatation of colon (toxic megacolon): etiology, treatment and prognosis in 42 patients. Medicine 1969;48:229.

    Article  PubMed  CAS  Google Scholar 

  8. Ransohoff D. Colon cancer in ulcerative colitis. Gastroenterology 1988;94:1089.

    PubMed  CAS  Google Scholar 

  9. Blackstone MO, Radial RH, Rogers BHG, et al. Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: an indication for colectomy. Gastroenterology 1981;80:366.

    PubMed  CAS  Google Scholar 

  10. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis IV. Carcinoma of the colon. Gut 1964;5:15.

    Article  Google Scholar 

  11. Michelassi F, Balestracci T, Chappell R, et al. Primary and recurrent Crohn’s disease: experience with 1379 patients. Ann Surg 1991;214(3):230–240.

    Article  PubMed  CAS  Google Scholar 

  12. Farmer RG, Hawk WA, Turnbull RG Jr. Clinical patterns in Crohn’s disease: statistical study of 615 cases. Gastroenterology 1975;68:627.

    PubMed  CAS  Google Scholar 

  13. Crohn BB, Yarnis H. Regional ileitis. 2nd ed. New York: Grune & Stratton 1958.

    Google Scholar 

  14. Homan WP, Tang CK, Thorbjarnason B. Acute massive hemorrhagae from intestinal Crohn’s disease. Arch Surg 1976;111:901.

    Article  PubMed  CAS  Google Scholar 

  15. Darke SG, Parks AG, Grogono JL, et al Adenocar-cinoma and Crohn’s disease: a report of two cases and analysis of the literature. Br J Surg 1973;60:169–175.

    Article  PubMed  CAS  Google Scholar 

  16. McCafferty TD, Nasr K, Lawrence AM, et al. Severe growth retardation in children with inflammatory bowel disease. Pediatrics 1970;45:386.

    Google Scholar 

  17. Homer DR, Grand RJ, Colodny AH. Growth course and prognosis after surgery for Crohn’s disease in children and adolescents. Pediatrics 1977;59:717.

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Michelassi, F. (1999). Indications for Surgical Treatment in Ulcerative Colitis and Crohn’s Disease. In: Michelassi, F., Milsom, J.W. (eds) Operative Strategies in Inflammatory Bowel Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-1396-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-1396-3_8

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7130-7

  • Online ISBN: 978-1-4612-1396-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics